Influence of chronic nicotine administration on cerebral Type 1 cannabinoid receptor binding: An in vivo micro-pet study in the rat using [ 18F]MK-9470

Journal of Molecular Neuroscience

Volumn 42, Issue 2, 2010, Pages 162-167

  Gérard, Nathalie ^a,b   Ceccarini, Jenny ^a,b   Bormans, Guy ^a   Vanbilloen, Bert ^a   Casteels, Cindy ^a,b   Goffin, Karolien ^a,b   Bosier, Barbara ^c   Lambert, Didier M ^c   Van Laere, Koen ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b KU Leuven   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Micro PET; Nicotine; Rat brain; Type 1 cannabinoid receptor

Indexed keywords

(N [2 (3 CYANO PHENYL) 3 (4 (2 FLUORETHOXY) PHENYL) 1 METHYLPROPYL] 2 (5 METHYL 2 PYRIDYLOXY) 2 METHYL PROPANAMIDE F 18; CANNABINOID 1 RECEPTOR; NICOTINE; RADIOLIGAND; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CEREBELLUM; FEMALE; IMAGE ANALYSIS; IN VIVO STUDY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN ANALYSIS; RAT; RECEPTOR BINDING; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE;

ANIMALS; BINDING, COMPETITIVE; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; CRICETULUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; NICOTINE; NICOTINIC AGONISTS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

RATTUS; RATTUS NORVEGICUS;

EID: 77956973721     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9340-2     Document Type: Article

References (31)

1. GN Balerio E Aso F Berrendero P Murtra R Maldonado 2004 Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice Eur J Neurosci 20 2737 2748 10.1111/j.1460-9568. 2004.03714.x 15548217 (Pubitemid 39573789)
2. CS Breivogel JM Walker SM Huang MB Roy SR Childers 2004 Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids Neuropharmacology 47 81 91 10.1016/j.neuropharm.2004.02.017 1:CAS:528:DC%2BD2cXksVagtbw%3D 15165836 (Pubitemid 38686313)
3. 18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor Proc Natl Acad Sci U S A 104 9800 9805 10.1073/pnas.0703472104 1:CAS:528:DC%2BD2sXmsFSmsLc%3D 17535893 (Pubitemid 47175347)
4. A Castane E Valjent C Ledent M Parmentier R Maldonado O Valverde 2002 Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence Neuropharmacology 43 857 867 10.1016/S0028-3908(02) 00118-1 1:CAS:528:DC%2BD38XnvVGqsLk%3D 12384171 (Pubitemid 35221396)
5. A Castane F Berrendero R Maldonado 2005 The role of the cannabinoid system in nicotine addiction Pharmacol Biochem Behav 81 381 386 10.1016/j.pbb.2005.01.025 1:CAS:528:DC%2BD2MXlt1Ggurc%3D 15925402 (Pubitemid 40807135)
6. C Casteels P Vermaelen J Nuyts, et al. 2006 Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain J Nucl Med 47 1858 1866 17079820
7. Casteels C, Vanbilloen B, Vercammen D et al (2010) Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding. Synapse (in press)
8. C Cohen G Perrault C Voltz R Steinberg P Soubrie 2002 SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats Behav Pharmacol 13 451 463 1:CAS:528:DC%2BD38XotFyru70%3D 12394421
9. C Cohen E Kodas G Griebel 2005 CB1 receptor antagonists for the treatment of nicotine addiction Pharmacol Biochem Behav 81 387 395 10.1016/j.pbb.2005.01. 024 1:CAS:528:DC%2BD2MXlt1Ggu74%3D 15935455 (Pubitemid 40807136)
10. JA Dani RA Harris 2005 Nicotine addiction and comorbidity with alcohol abuse and mental illness Nat Neurosci 8 1465 1470 10.1038/nn1580 1:CAS:528:DC%2BD2MXhtFCrurbJ 16251989 (Pubitemid 41573657)
11. WA Devane FAI Dysarz MR Johnson LS Melvin AC Howlett 1988 Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 605 613 1:CAS:528:DyaL1MXovVersQ%3D%3D 2848184
12. V Di Marzo M Bifulco L De Petrocellis 2004 The endocannabinoid system and its therapeutic exploitation Nat Rev Drug Discov 3 771 784 10.1038/nrd1495 15340387 (Pubitemid 39242829)
13. 18F]MK-9470 micro-PET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam Neuropharmacology 54 1103 1106 10.1016/j.neuropharm.2008.02.018 1:CAS:528:DC%2BD1cXlslWhsLc%3D 18423778
14. S Gonzalez MG Cascio J Fernandez-Ruiz F Fezza V Di Marzo JA Ramos 2002 Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine Brain Res 954 73 81 10.1016/S0006-8993(02)03344-9 1:CAS:528:DC%2BD38XotVektL0%3D 12393235 (Pubitemid 35223443)
15. SJ Govaerts E Hermans DM Lambert 2004 Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors Eur J Pharm Sci 23 233 243 10.1016/j.ejps.2004.07.013 1:CAS:528:DC%2BD2cXos1ers7Y%3D 15489124 (Pubitemid 39369878)
16. M Herkenham AB Lynn MD Little, et al. 1990 Cannabinoid receptor localization in brain Proc Natl Acad Sci U S A 87 1932 1936 10.1073/pnas.87.5. 1932 1:CAS:528:DyaK3cXhsFWktLs%3D 2308954
17. R Maldonado O Valverde F Berrendero 2006 Involvement of the endocannabinoid system in drug addiction Trends Neurosci 29 225 232 10.1016/j.tins.2006.01.008 1:CAS:528:DC%2BD28Xjs1Wmurw%3D 16483675
18. EM Marco O Granstrem E Moreno, et al. 2007 Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats Eur J Pharmacol 557 37 43 10.1016/j.ejphar.2006.11.013 1:CAS:528:DC%2BD2sXhtVKntr0%3D 17174300 (Pubitemid 46135558)
19. S Miksys E Hoffmann RF Tyndale 2000 Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment Biochem Pharmacol 59 1501 1511 10.1016/S0006-2952(00)00281-1 1:CAS:528: DC%2BD3cXivVGntb8%3D 10799646 (Pubitemid 30229882)
20. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, Orlando
21. LA Reno W Zago RP Markus 2004 Release of [(3)H]-l-glutamate by stimulation of nicotinic acetylcholine receptors in rat cerebellar slices Neuroscience 124 647 653 10.1016/j.neuroscience.2003.12.023 1:CAS:528: DC%2BD2cXhsFWnurg%3D 14980735 (Pubitemid 38251330)
22. J Romero L Garcia JJ Fernandez-Ruiz M Cebeira JA Ramos 1995 Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol Pharmacol Biochem Behav 51 731 737 10.1016/0091-3057(95)00023-P 1:CAS:528: DyaK2MXmsFCnt7o%3D 7675852
23. JE Rose FM Behm AN Salley, et al. 2007 Regional brain activity correlates of nicotine dependence Neuropsychopharmacology 32 2441 2452 10.1038/sj.npp.1301379 1:CAS:528:DC%2BD2sXhtlWjsbnL 17356570 (Pubitemid 350126832)
24. 18F]MK-9470 in human brain. Eur J Nucl Med Mol Imaging (in press)
25. LJ Sim-Selley BR Martin 2002 Effect of chronic administration of R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1, 2, 3-de]-1, 4-b enzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55, 212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice J Pharmacol Exp Ther 303 36 44 10.1124/jpet.102.035618 1:CAS:528: DC%2BD38XnsV2qsr8%3D 12235230
26. EC Siu RF Tyndale 2007 Non-nicotinic therapies for smoking cessation Annu Rev Pharmacol Toxicol 47 541 564 10.1146/annurev.pharmtox.47.120505.105354 1:CAS:528:DC%2BD2sXit1altbg%3D 17209799
27. GE Terry JS Liow SS Zoghbi, et al. 2009 Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand Neuroimage 48 362 370 10.1016/j.neuroimage.2009.06. 059 19573609
28. E Valjent JM Mitchell MJ Besson J Caboche R Maldonado 2002 Behavioural and biochemical evidence for interactions between delta 9-tetrahydrocannabinol and nicotine Br J Pharmacol 135 564 578 10.1038/sj.bjp.0704479 1:CAS:528:DC%2BD38Xht1Krt78%3D 11815392
29. K Van Laere K Goffin C Casteels, et al. 2008 Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET Neuroimage 39 1533 1541 10.1016/j.neuroimage.2007.10. 053 18077184
30. MP Viveros EM Marco SE File 2006 Nicotine and cannabinoids: parallels, contrasts and interactions Neurosci Biobehav Rev 30 1161 1181 10.1016/j.neubiorev.2006.08.002 1:CAS:528:DC%2BD28Xht12ksL7F 17049986 (Pubitemid 44856747)
31. LL Werling SC Reed D Wade S Izenwasser 2009 Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats Int J Dev Neurosci 27 263 269 10.1016/j.ijdevneu.2008. 12.008 1:CAS:528:DC%2BD1MXivVWrsLY%3D 19167478